US FDA approves improved rapid at-home COVID test kit as hotspots face acute shortage

By:
On:
In: International News
With: 0 Comments

As the United States is grappling to meet demands for at-home COVID testing kits fuelled by skyrocketing COVID-19 cases coinciding with Omicron, Food and Drug Administration (FDA) on Friday approved Swiss pharmaceutical company Roche’s improved rapid at-home test kits. In a statement released by the company, Roche announced that its at-home COVID test kits have been endorsed for…Continue Reading